Vanda Pharmaceuticals(VNDA)
Search documents
Vanda Pharmaceuticals(VNDA) - 2019 Q2 - Earnings Call Transcript
2019-08-01 02:37
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2019 Earnings Conference Call July 31, 2019 4:30 PM ET Company Participants James Kelly - Chief Financial Officer Mihael Polymeropoulos - President and Chief Executive Officer Conference Call Participants Roy Buchanan - JMP Securities LLC Chris Howerton - Jefferies Group LLC Joel Beatty - Citigroup Inc. Derek Archila - Stifel Financial Corp. Operator Good day, ladies and gentlemen, and welcome to Vanda PharmaceuticalsÂ' Second Quarter 2019 Earnings Conference call ...
Vanda Pharmaceuticals(VNDA) - 2019 Q1 - Earnings Call Transcript
2019-05-02 01:48
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2019 Results Earnings Conference Call May 1, 2019 4:30 AM ET Company Participants Jim Kelly - Executive Vice President, Chief Financial Officer, Treasurer Mihael Polymeropoulos - President and Chief Executive Officer Conference Call Participants Chris Howerton - Jefferies Joel Beatty - Citi Derek Archila - Stifel Esther Rajavelu - Oppenheimer Operator Good day ladies and gentlemen and welcome to the Vanda Pharmaceuticals' first quarter 2019 earnings conference cal ...
Vanda Pharmaceuticals (VNDA) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
2019-03-11 19:45
CORPORATE PRESENTATION 2019 March 11, 2019 Forward-Looking Statements Various statements in this presentation, including, but not limited to, Vanda's financial guidance for 2019, are "forward-looking statements" under the securities laws. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions, and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements in ...
Vanda Pharmaceuticals(VNDA) - 2018 Q4 - Earnings Call Transcript
2019-02-14 05:56
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2018 Earnings Conference Call February 13, 2019 4:30 PM ET Company Participants James Kelly - EVP and CFO Mihael Polymeropoulos - President and CEO Conference Call Participants Chris Howerton - Jefferies Joel Beatty - Citi Jason Butler - JMP Securities Pete Stavropoulos - Cantor Fitzgerald Esther Rajavelu - Oppenheimer Derek Archila - Stifel Operator Good day ladies and gentlemen and welcome to the Vanda PharmaceuticalÂ's fourth quarter 2018 earnings conference ca ...